Coronavirus India Update: Covaxin likely to get approval from WHO, total Covid-19 vaccination crosses 75 crore

Publish Date: 14 Sep, 2021 |
 

Covaxin WHO approval:

Hyderabad-based vaccine manufacturing company Bharat Biotech's indigenous Covid-19 vaccine Covaxin may get approval from the World Health Organization (WHO) this week, as reported by various sources. The central government had informed Parliament in July that it had submitted all the documents required for the Emergency Use List (EUL).

The WHO usually takes up to six weeks after the submission of a decision document on the Emergency Use List (EUL). It must be noted that earlier in June, WHO accepted Bharat Biotech's EOI i.e. Expression of Interest.

In this regard, Dr. NK Arora, Chairman of the COVID Working Group, said that within this week we should be able to obtain the WHO Emergency Use List (EUL) for Covaxin. Hopefully, the vaccine should be given international recognition so that people traveling abroad face less hardship.

Earlier, WHO's assistant director-general for vaccines, Mariangela Simao said the UN health agency's assessment of the India Biotech Vaccine was "much better". Officials were expected to get the approval by mid-September.

Many countries have not recognized Covaxin:

Covaxin is an indigenous vaccine of India. At present, the central government has approved the emergency use of this vaccine and it is also available to the common people, which has been developed jointly by ICMR and Bharat Biotech. So far, this vaccine is no longer included in the World Health Organization's list of emergency use, due to which many countries have not approved travel for people who have got the vaccine.

It must be noted that, due to the delay in approval from WHO, Bharat Biotech is facing hurdles in getting Covaxin approval in some countries. After the approval of this vaccine by the WHO, the chances of getting Covaxin worldwide recognition will increase.


 

Related videos

यह भी पढ़ें

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy.Accept